Drug Trial Radar · NCT05029635
Phase III Study on HMPL-523 for Treatment of ITP
Last checked: Nov 19, 2026Latest source record: May 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
272
Actual
Start
Oct 27, 2021
Primary completion
May 16, 2025
Study completion Sep 18, 2025
Sponsor
- Lead sponsor
- HutchmedIndustry
- Sponsor type
- Industry
- First posted
- Aug 31, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether HMPL-523 (sovleplenib) is safe and effective in the treatment of chronic Immune Thrombocytopenic Purpura (ITP).
Conditions
- Primary Immune Thrombocytopenia (ITP)
Interventions
HMPL-523Drug
HMPL-523(300mg PO QD)
PlaceboDrug
Placebo(300mg PO QD)
Primary outcomes
What the sponsor says the trial is designed to measure.
- the durable response rate in the primary studyTime frame: treatment period Week14-Week24
Locations
37 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
The First Affiliated hospital of USTC
Hefei, Anhui, China
Beijing Chaoyang Hospital of Capital Medical University
Beijing, Beijing Municipality, China
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
People's Hospital of Peking University
Beijing, Beijing Municipality, China
Fujian Medical University Union Hospital
Fuzhou, Fujian, China
Lanzhou University Second Hospital
Lanzhou, Gansu, China
Guangdong General Hospital
Guangzhou, Guangdong, China
Southern Hospital of Southern Medical University
Guangzhou, Guangdong, China
The Second People's Hospital Of Shenzhen
Shenzhen, Guangdong, China
The First Affiliated Hospital Of GuangXi Medical University
Nanning, Guangxi, China
The First Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Affiliated Hospital of North China University of Technology
Tangshan, Hebei, China
First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Henan Cancer Hospital
Zhengzhou, Henan, China
Union Hospital affiliated to Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Xiangyang Central Hospital
Xiangyang, Hubei, China
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China
Xiangya Hospital Central South University
Changsha, Hunan, China
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
The Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University
Huai'an, Nanjing Province, China
Qinghai province people's hospital
Xining, Qinghai, China
Jinan Central Hospital Affilated to Sandong University
Jinan, Shandong, China
LiaoCheng People's Hospital
Liaocheng, Shandong, China
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, China
Jinshan Hospital Affiliated To Fudan University
Shanghai, Shanghai Municipality, China
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China
Heping Hospital Affiliated to Changzhi Medical College
Changzhi, Shanxi, China
The second hospital of Shanxi Medical University
Taiyuan, Shanxi, China
Shanxi Provincial People's Hospital
Xi’an, Shanxi, China
West China Hospital,Sichuan University
Chengdu, Sichuan, China
The First Affilicated Hospital of Xinjiang Medical University
Ürümqi, The Xinjiang Uygur Autonomous Region, China
Blood Institute of the Chinese Academy of Medical Sciences
Tianjin, Tianjin Municipality, China
The second Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
Zhejiang Provincial Hospital of Chinese Medicine
Hangzhou, Zejiang Province, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.